XML 15 R5.htm IDEA: XBRL DOCUMENT v3.22.2.2
Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Total
Beginning balance, value at Dec. 31, 2020 $ 350,749 $ 64,526,664 $ (57,086,943) $ 7,790,470
Beginning balance, shares at Dec. 31, 2020 35,074,922      
Net income (loss) (545,520) (545,520)
Stock option exercises $ 2,879 376,268 379,147
Stock option exercises, shares 287,932      
Stock-based compensation 404,718 404,718
Ending balance, value at Mar. 31, 2021 $ 353,628 65,307,650 (57,632,463) 8,028,815
Ending balance, shares at Mar. 31, 2021 35,362,854      
Beginning balance, value at Dec. 31, 2020 $ 350,749 64,526,664 (57,086,943) 7,790,470
Beginning balance, shares at Dec. 31, 2020 35,074,922      
Net income (loss)       (399,535)
Ending balance, value at Sep. 30, 2021 $ 458,601 89,074,838 (57,486,478) 32,046,961
Ending balance, shares at Sep. 30, 2021 45,856,351      
Beginning balance, value at Mar. 31, 2021 $ 353,628 65,307,650 (57,632,463) 8,028,815
Beginning balance, shares at Mar. 31, 2021 35,362,854      
Net income (loss) (1,553,911) (1,553,911)
Stock option exercises $ 2,722 339,541 342,263
Stock option exercises, shares 268,385      
Stock-based compensation 211,124 211,124
Ending balance, value at Jun. 30, 2021 $ 356,350 65,858,315 (59,186,374) 7,028,291
Ending balance, shares at Jun. 30, 2021 35,631,239      
Net income (loss) 1,699,896 1,699,896
Stock option exercises $ 2,251 428,599 430,850
Stock option exercises, shares 225,112      
Stock-based compensation   157,875 157,875
Public offering equity, net of issuance costs $ 100,000 22,630,049 22,730,049
Public offering equity, net of issuance costs, shares 10,000,000      
Ending balance, value at Sep. 30, 2021 $ 458,601 89,074,838 (57,486,478) 32,046,961
Ending balance, shares at Sep. 30, 2021 45,856,351      
Beginning balance, value at Dec. 31, 2021 $ 458,850 89,313,273 (59,285,610) 30,486,513
Beginning balance, shares at Dec. 31, 2021 45,885,043      
Net income (loss) (2,538,500) (2,538,500)
Stock option exercises $ 1,807 97,362 99,169
Stock option exercises, shares 180,774      
Stock-based compensation 562,875 562,875
Ending balance, value at Mar. 31, 2022 $ 460,657 89,973,510 (61,824,110) 28,610,057
Ending balance, shares at Mar. 31, 2022 46,065,817      
Beginning balance, value at Dec. 31, 2021 $ 458,850 89,313,273 (59,285,610) 30,486,513
Beginning balance, shares at Dec. 31, 2021 45,885,043      
Net income (loss)       (11,027,640)
Ending balance, value at Sep. 30, 2022 $ 465,786 90,515,197 (70,313,249) 20,667,734
Ending balance, shares at Sep. 30, 2022 46,578,730      
Beginning balance, value at Mar. 31, 2022 $ 460,657 89,973,510 (61,824,110) 28,610,057
Beginning balance, shares at Mar. 31, 2022 46,065,817      
Net income (loss) (4,426,559) (4,426,559)
Stock option exercises $ 2,501 135,134 137,635
Stock option exercises, shares 250,141      
Stock-based compensation 272,480 272,480
Ending balance, value at Jun. 30, 2022 $ 463,158 90,381,124 (66,250,669) 24,593,613
Ending balance, shares at Jun. 30, 2022 46,315,958      
Net income (loss) (4,062,580) (4,062,580)
Stock-based compensation   136,701   136,701
Common stock issued for vested restricted stock units $ 2,628 (2,628)
Common stock issued for vested restricted stock units, shares 262,772      
Ending balance, value at Sep. 30, 2022 $ 465,786 $ 90,515,197 $ (70,313,249) $ 20,667,734
Ending balance, shares at Sep. 30, 2022 46,578,730